# VIDA Global Inc.: financial statements, quarterly

VIDA · NYSE · CIK 1973062 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vida.md) · [Financials](/companies/vida/financials.md) · [Filings](/companies/vida/filings.md) · [Insiders](/companies/vida/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vida/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $k | [35.7](/filings/0001493152-26-030343.md) | [73.0](/filings/0001493152-26-038335.md) | [306](/filings/0001493152-26-030343.md) | [324](/filings/0001493152-26-038335.md) |
| Cost of revenue | $k | [75.9](/filings/0001493152-26-030343.md) | [83.7](/filings/0001493152-26-038335.md) | [146](/filings/0001493152-26-030343.md) | [166](/filings/0001493152-26-038335.md) |
| Selling, general and administrative | $k | [111](/filings/0001493152-26-030343.md) | [141](/filings/0001493152-26-038335.md) | [231](/filings/0001493152-26-030343.md) | [587](/filings/0001493152-26-038335.md) |
| Operating income | $k | [(407)](/filings/0001493152-26-030343.md) | [(331)](/filings/0001493152-26-038335.md) | [(887)](/filings/0001493152-26-030343.md) | [(1,469)](/filings/0001493152-26-038335.md) |
| Interest expense | $k | not reported | not reported | not reported | [1.2](/filings/0001493152-26-038335.md) |
| Income tax | $k | [0.0](/filings/0001493152-26-030343.md) | not reported | not reported | not reported |
| Net income | $k | [(522)](/filings/0001493152-26-030343.md) | [(71.0)](/filings/0001493152-26-038335.md) | [(1,112)](/filings/0001493152-26-030343.md) | [(1,568)](/filings/0001493152-26-038335.md) |
| Diluted EPS | $ per share | [(0.16)](/filings/0001493152-26-030343.md) | [(0.02)](/filings/0001493152-26-038335.md) | [(0.25)](/filings/0001493152-26-030343.md) | [(0.16)](/filings/0001493152-26-038335.md) |
| Basic EPS | $ per share | [(0.16)](/filings/0001493152-26-030343.md) | [(0.02)](/filings/0001493152-26-038335.md) | [(0.25)](/filings/0001493152-26-030343.md) | [(0.16)](/filings/0001493152-26-038335.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | [2.3](/filings/0001493152-26-038335.md) | [1.4](/filings/0001493152-26-030343.md) | [14.5](/filings/0001493152-26-038335.md) |
| Current assets | $m | not reported | not reported | not reported | [2.8](/filings/0001493152-26-038335.md) | [2.1](/filings/0001493152-26-030343.md) | [15.0](/filings/0001493152-26-038335.md) |
| Total assets | $m | not reported | not reported | not reported | [6.1](/filings/0001493152-26-038335.md) | [5.3](/filings/0001493152-26-030343.md) | [18.2](/filings/0001493152-26-038335.md) |
| Current liabilities | $m | not reported | not reported | not reported | [0.3](/filings/0001493152-26-038335.md) | [0.4](/filings/0001493152-26-030343.md) | [0.8](/filings/0001493152-26-038335.md) |
| Total liabilities | $m | not reported | not reported | not reported | [0.3](/filings/0001493152-26-038335.md) | [0.4](/filings/0001493152-26-030343.md) | [0.8](/filings/0001493152-26-038335.md) |
| Shareholders' equity | $m | [3.6](/filings/0001493152-26-038335.md) | [3.2](/filings/0001493152-26-038335.md) | [3.3](/filings/0001493152-26-038335.md) | [5.8](/filings/0001493152-26-038335.md) | [4.9](/filings/0001493152-26-038335.md) | [17.3](/filings/0001493152-26-038335.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(194)](/filings/0001493152-26-030343.md) | [(124) d](/filings/0001493152-26-038335.md) | [(778)](/filings/0001493152-26-030343.md) | [(720) d](/filings/0001493152-26-038335.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,203](/filings/0001493152-26-030343.md) | [4,369](/filings/0001493152-26-038335.md) | [4,430](/filings/0001493152-26-030343.md) | [9,547](/filings/0001493152-26-038335.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.